These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 13704532)

  • 1. [Comparative efficacy of some peripheral vasodilators by a method utilizing an albumin labeled with iodine-131].
    GERAUD J; BRU A; BES A; RASCOL A; d' ANDRIESENS
    Presse Med (1893); 1961 Apr; 69():807-9. PubMed ID: 13704532
    [No Abstract]   [Full Text] [Related]  

  • 2. A quantitative appraisal of the value of vasodilators in occlusive peripheral arterial disease.
    GILLESPIE JA
    Bull Soc Int Chir; 1962; 21():69-72. PubMed ID: 13898634
    [No Abstract]   [Full Text] [Related]  

  • 3. Vasodilators and the use of cyclospasmol in peripheral vascular disease.
    MAHL MM
    Angiology; 1961 Sep; 12():432-4. PubMed ID: 13765381
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapeutic trial of a vasodilator in arteriopathy of the extremities. Evaluation of results and discussion on the use of vasodilators in arteritis].
    PIERRON J
    Mars Med; 1960; 97():641-5. PubMed ID: 14432867
    [No Abstract]   [Full Text] [Related]  

  • 5. Vasodilator drugs for peripheral vascular disease.
    GOODWIN JF
    Br Med J; 1960 Jun; 1(5188):1800-3. PubMed ID: 13851099
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of peripheral vascular diseases with a new vasodilator agent].
    MARINONI E; ZUCCHI C
    Minerva Cardioangiol; 1960 Dec; 8():597-607. PubMed ID: 13766848
    [No Abstract]   [Full Text] [Related]  

  • 7. [Duvadilan: a new peripheral vasodilator].
    MARTORELL A
    Angiologia; 1959; 11():241-4. PubMed ID: 14421881
    [No Abstract]   [Full Text] [Related]  

  • 8. [Dilatropon in the treatment of peripheral vascular diseases].
    FABI M
    Arcisp S Anna Ferrara; 1959; 12():75-84. PubMed ID: 13821185
    [No Abstract]   [Full Text] [Related]  

  • 9. Combined vasodilator therapy in peripheral vascular diseases.
    POPKIN RJ
    J Am Geriatr Soc; 1960 Aug; 8():638-43. PubMed ID: 14434109
    [No Abstract]   [Full Text] [Related]  

  • 10. Use of a new vasodilator agent in management of peripheral arterial insufficiency.
    SAMUELS SS; SHAFTEL HE
    J Am Med Assoc; 1959 Sep; 171():142-5. PubMed ID: 14441294
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the use in medical therapy of peripheral arteriopathies of an enzymatic complex in association with a peripheral vasodilator].
    STARACE G; NOFERI A
    Minerva Cardioangiol; 1959 Oct; 7():545-50. PubMed ID: 13833816
    [No Abstract]   [Full Text] [Related]  

  • 12. [Contribution to the clinical study of a new vasodilator].
    BENINI P; COSSU G
    Minerva Chir; 1960 Apr; 15():429-44. PubMed ID: 13798881
    [No Abstract]   [Full Text] [Related]  

  • 13. Peripheral vasodilation: methods of evaluation and the correlation with clinical practice.
    KAINDI F
    Angiology; 1960 Feb; 11():15-20. PubMed ID: 14404025
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of cyclandelate (cyclospasmol) in treatment of circulatory disturbances.
    LESLIE RE
    Tex State J Med; 1960 May; 56():352-6. PubMed ID: 14415999
    [No Abstract]   [Full Text] [Related]  

  • 15. [A new vasodilator in the functional therapy of peripheral arteriopathies: 1-(p-hydroxyphenyl)-2-(1-methyl-2-phenoxyethylamino)-propanol HC1].
    FERRANTE G; GRASS IM; NEGRO G
    Minerva Cardioangiol; 1960 Jun; 8():288-95. PubMed ID: 13822372
    [No Abstract]   [Full Text] [Related]  

  • 16. [On a new method of therapy of peripheral and cerebral circulatory disorders with 3-(methyioxyethylamino)-2-hydroxypropyltheophylline-beta-pyridinecarboxylic acid (complamin)].
    THIESEN J; FISCHER T
    Medizinische; 1959 Aug; 31-32():1427-32. PubMed ID: 13837851
    [No Abstract]   [Full Text] [Related]  

  • 17. [Use of a product of esterification of mandelic acid with 3,5,5-triethylcyclohexanol (cyclospasmol) in the treatment of peripheral arteriopathy].
    STARACE G; NOFERI A; PADULA R
    Gazz Med Ital; 1960 Apr; 119():133-6. PubMed ID: 13833815
    [No Abstract]   [Full Text] [Related]  

  • 18. [First notes on the use of a new vasodilator, Caa 40, in leg ulcers].
    DUGOIS P; COLOMB L; GAGNAIRE J
    Bull Soc Fr Dermatol Syphiligr; 1959; 66():213-4. PubMed ID: 13818502
    [No Abstract]   [Full Text] [Related]  

  • 19. [Actein, a fluid extract from Actaea racemosa, in the medical therapy of peripheral arteriopathies].
    STARACE G; NOFERI A; SALDAMARCO G
    Clin Ter; 1962 May; 22():823-9. PubMed ID: 13916295
    [No Abstract]   [Full Text] [Related]  

  • 20. A clinical study of a musculotropic vasodilating compound.
    SHAFTEL HE; SAMUELS S; PADERNACHT E
    Angiology; 1961 Sep; 12():423-6. PubMed ID: 13750570
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.